Skip to main content

Table 1 Pre-existing PRNT50 titer and subsequent dengue infection in subjects with low titer (<90) to subsequent infecting serotype

From: Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand

Subject code

PRNT50 titer (Feb 2006)

Date of illness

Clinical diagnosis

ELISA test resulta

Serotype isolated

D1

D2

D3

D4

JE

03-146

<10

<10

<10

<10

155

11/10/2006

DF

Secondary

D1

05-119

<10

<10

<10

<10

235

9/6/2006

Pharyngitis

Secondary

D1

05-181

<10

<10

<10

<10

<10

21/8/2006

DF

Primary

D1

05-310

10

<10

167

<10

250

21/4/2006

DF

Secondary

D1

07-479

<10

<10

<10

<10

29

23/7/2006

DF

Secondary

D1

07-383

13

<10

<10

<10

<10

10/9/2006

DF

Primary

D1

04-276

13

<10

<10

<10

<10

13/3/2006

DF

Primary

D1

05-357

40

29

27

<10

303

10/10/2006

Bronchitis

Secondary

D1

05-002

50

<10

<10

<10

396

25/11/2006

DF

Secondary

D1

03-097

75

1134

24

20

1307

7/10/2006

DF

Secondary

D1

05-339

<10

<10

<10

<10

503

28/8/2006

Pharyngitis

Secondary

D2

04-322

17

<10

<10

<10

165

9/11/2006

DF

Secondary

D3

04-325

<10

<10

<10

<10

685

23/10/2006

DHF gr2

Secondary

D3

02-189

<10

10

12

<10

<10

6/7/2006

DF

Primary

D3

01-227

49

<10

<10

<10

590

19/2/2006

Pharyngitis

Secondary

D4

01-254

12450

3348

32

<10

78

28/2/2006

AGE

Secondary

D4

01-384

<10

<10

<10

<10

92

19/12/2006

Pharyngitis

Secondary

D4

06-164

210

540

12040

21

76

30/8/2006

DF

Secondary

D4

01-124

228

135

516

39

28

31/3/2006

DF

Secondary

D4

05-257

3141

194

272

41

726

15/10/2006

Common cold

Secondary

D4

01-224

195

2901

220

50

802

9/3/2006

DHF gr1

Secondary

D4

05-378

6238

2204

676

75

43

28/7/2006

DF

Secondary

D4

  1. aELISA result showed either primary or secondary infection.
  2. AGE: acute gastroenteritis; D: dengue virus; DF: dengue fever; DHF: dengue hemorrhagic fever; gr: grade; JE: Japanese encephalitis virus; PRNT50: 50% plaque reduction neutralization.